aminocaproic acid has been researched along with Cystic Fibrosis in 3 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
Excerpt | Relevance | Reference |
---|---|---|
"Hemoptysis is a major cause of morbidity and mortality in patients with cystic fibrosis (CF)." | 1.51 | Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis. ( Al-Samkari, H; Cardoni, L; Connors, JM; McMahon, L; Perkins, R; Pighetti, EH; Rits, S; Shin, K; Uluer, A, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Samkari, H | 1 |
Shin, K | 1 |
Cardoni, L | 1 |
Pighetti, EH | 1 |
Rits, S | 1 |
McMahon, L | 1 |
Perkins, R | 1 |
Uluer, A | 1 |
Connors, JM | 1 |
Peterson, KL | 1 |
DeCampli, WM | 1 |
Feeley, TW | 1 |
Starnes, VA | 1 |
Costello, CM | 1 |
McQuaid, K | 1 |
O'Connor, CM | 1 |
Fitzgerald, MX | 1 |
3 other studies available for aminocaproic acid and Cystic Fibrosis
Article | Year |
---|---|
Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Critical Pathways; Cystic Fibrosis; Drug Monitori | 2019 |
Blood loss and transfusion requirements in cystic fibrosis patients undergoing heart-lung or lung transplantation.
Topics: Adult; Aminocaproic Acid; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Child; Cystic Fibrosis | 1995 |
Effect of the addition of protease inhibitors to sputa from cystic fibrosis patients.
Topics: alpha 1-Antitrypsin; Aminocaproic Acid; Cystic Fibrosis; Edetic Acid; Ethylmaleimide; Humans; Isoflu | 1994 |